Would you treat a patient with an early stage favorable breast cancer who has synchronous advanced (or metastatic) NSCLC?

Unfortunately, despite recent advances, the survival for locally advanced or metastatic NSCLC remains poor. As someone who treats both lung and breast, I would have a multi-disciplinary discussion with the teams regarding any added benefit of treating the early stage breast cancer. I think the facto...